Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The current epidemiology of invasive pneumococcal disease (IPD) in children after introduction of 13-valent pneumococcal conjugate vaccine (PCV13)

Next Previous
Trial Profile

The current epidemiology of invasive pneumococcal disease (IPD) in children after introduction of 13-valent pneumococcal conjugate vaccine (PCV13)

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jan 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 20 Jan 2020 Results of preliminary framework predicting the patterns of vaccine failure pneumococcal disease cases which may be used in decision making process on the number of doses required for selected populations were published in the Vaccine
  • 19 Nov 2018 New trial record
  • 07 Oct 2018 Results (n=351) presented at the IDWeek 2018

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top